Versavel, Mark

Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations

Edwards, R. R., Dworkin, R. H., Turk, D. C., Angst, M. S., Dionne, R., Freeman, R., Hansson, P., Haroutounian, S., Arendt-Nielsen, L., Attal, N., et al. (2016) · Pain

Musculoskeletal pain and rehabilitationPain Mechanisms and Treatments

Cited by 403

Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder: A 6-Month, Randomized, Placebo-Controlled, Double-Blind Trial

Bowden, C. L., Vieta, E., Ice, K. S., Schwartz, J. H., Wang, P. P., & Versavel, M. (2010) · The Journal of Clinical Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 144

Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP‐432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects

Sramek, J. J., Hardy, L. W., Bieck, P., Zamora, C., Versavel, M., Kharidia, J., Grinnell, T., Chen, Y., Sullivan, M., Ding, H., et al. (2016) · CNS Neuroscience & Therapeutics

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 5